Adapting Mass Spectrometry-based Platforms for Clinical Proteomics Applications: The Capillary Electrophoresis Coupled Mass Spectrometry Paradigm

Overview

Journal Crit Rev Clin Lab Sci

Publisher Informa Healthcare

Specialty Pathology

Date 2009 May 1

PMID 19404829

Citations 5

Authors

Jochen Metzger

Peter B Luppa

David M Good

Harald Mischak

Affiliations

Soon will be listed here.

Abstract

Single biomarker detection is common in clinical laboratories due to the currently available method spectrum. For various diseases, however, no specific single biomarker could be identified. A strategy to overcome this diagnostic void is to shift from single analyte detection to multiplexed biomarker profiling. Mass spectrometric methods were employed for biomarker discovery in body fluids. The enormous complexity of biofluidic proteome compartments implies upstream fractionation. For this reason, mass spectrometry (MS) was coupled to two-dimensional gel electrophoresis, liquid chromatography, surface-enhanced laser desorption/ionization, or capillary electrophoresis (CE). Differences in performance and operating characteristics make them differentially suited for routine laboratory applications. Progress in the field of clinical proteomics relies not only on the use of an adequate technological platform, but also on a fast and efficient proteomic workflow including standardized sample preparation, proteomic data processing, statistical validation of biomarker selection, and sample classification. Based on CE-MS analysis, we describe how proteomic technology can be implemented in a clinical laboratory environment. In the last part of this review, we give an overview of CE-MS-based clinical studies and present information on identity and biological significance of the identified peptide biomarkers providing evidence of disease-induced changes in proteolytic processing and posttranslational modification.

Citing Articles

Peptidomics and Capillary Electrophoresis.

Stepanova S, Kasicka V Adv Exp Med Biol. 2021; 1336:87-104.

PMID: 34628628 DOI: 10.1007/978-3-030-77252-9_5.

A nano LC-MALDI mass spectrometry droplet interface for the analysis of complex protein samples.

Pereira F, Niu X, deMello A PLoS One. 2013; 8(5):e63087.

PMID: 23671657 PMC: 3650041. DOI: 10.1371/journal.pone.0063087.

A distinct urinary biomarker pattern characteristic of female Fabry patients that mirrors response to enzyme replacement therapy.

Kistler A, Siwy J, Breunig F, Jeevaratnam P, Scherl A, Mullen W PLoS One. 2011; 6(6):e20534.

PMID: 21698285 PMC: 3115947. DOI: 10.1371/journal.pone.0020534.

Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles.

Sugimoto M, Wong D, Hirayama A, Soga T, Tomita M Metabolomics. 2010; 6(1):78-95.

PMID: 20300169 PMC: 2818837. DOI: 10.1007/s11306-009-0178-y.

Application of proteomic analysis to the study of renal diseases.

Welberry Smith M, Banks R, Wood S, Lewington A, Selby P Nat Rev Nephrol. 2009; 5(12):701-12.

PMID: 19859072 DOI: 10.1038/nrneph.2009.183.

References

Weissinger E, Wittke S, Kaiser T, Haller H, Bartel S, Krebs R . Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Kidney Int. 2004; 65(6):2426-34. DOI: 10.1111/j.1523-1755.2004.00659.x. View

Lescuyer P, Hochstrasser D, Rabilloud T . How shall we use the proteomics toolbox for biomarker discovery?. J Proteome Res. 2007; 6(9):3371-6. DOI: 10.1021/pr0702060. View

Wittke S, Fliser D, Haubitz M, Bartel S, Krebs R, Hausadel F . Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers. J Chromatogr A. 2003; 1013(1-2):173-81. DOI: 10.1016/s0021-9673(03)00713-1. View

Noji Y, Kajinami K, Kawashiri M, Todo Y, Horita T, Nohara A . Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis. Clin Chem Lab Med. 2001; 39(5):380-4. DOI: 10.1515/CCLM.2001.060. View

Mogensen C . Systemic blood pressure and glomerular leakage with particular reference to diabetes and hypertension. J Intern Med. 1994; 235(4):297-316. DOI: 10.1111/j.1365-2796.1994.tb01080.x. View

Decramer S, Wittke S, Mischak H, Zurbig P, Walden M, Bouissou F . Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat Med. 2006; 12(4):398-400. DOI: 10.1038/nm1384. View

Jennette J, Falk R . Pathogenic potential of anti-neutrophil cytoplasmic autoantibodies. Adv Exp Med Biol. 1993; 336:7-15. DOI: 10.1007/978-1-4757-9182-2_2. View

Kolch W, Neususs C, Pelzing M, Mischak H . Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery. Mass Spectrom Rev. 2005; 24(6):959-77. DOI: 10.1002/mas.20051. View

Cutillas P, Norden A, Cramer R, Burlingame A, Unwin R . Detection and analysis of urinary peptides by on-line liquid chromatography and mass spectrometry: application to patients with renal Fanconi syndrome. Clin Sci (Lond). 2003; 104(5):483-90. DOI: 10.1042/CS20020342. View

10.

Comper W, Osicka T, Clark M, MacIsaac R, Jerums G . Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay. Kidney Int. 2004; 65(5):1850-5. DOI: 10.1111/j.1523-1755.2004.00585.x. View

11.

Schiffer E, Mischak H, Novak J . High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS. Proteomics. 2006; 6(20):5615-27. DOI: 10.1002/pmic.200600230. View

12.

Anderson N, Anderson N . The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2002; 1(11):845-67. DOI: 10.1074/mcp.r200007-mcp200. View

13.

Blok L, Chang G, van Weerden W, Swarts H, de Pont J, van Steenbrugge G . Regulation of expression of Na+,K+-ATPase in androgen-dependent and androgen-independent prostate cancer. Br J Cancer. 1999; 81(1):28-36. PMC: 2374343. DOI: 10.1038/sj.bjc.6690647. View

14.

Gaspari M, Verhoeckx K, Verheij E, van der Greef J . Integration of two-dimensional LC-MS with multivariate statistics for comparative analysis of proteomic samples. Anal Chem. 2006; 78(7):2286-96. DOI: 10.1021/ac052000t. View

15.

Rossing K, Mischak H, Dakna M, Zurbig P, Novak J, Julian B . Urinary proteomics in diabetes and CKD. J Am Soc Nephrol. 2008; 19(7):1283-90. PMC: 2440301. DOI: 10.1681/ASN.2007091025. View

16.

Blankenberg S, Rupprecht H, Poirier O, Bickel C, Smieja M, Hafner G . Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation. 2003; 107(12):1579-85. DOI: 10.1161/01.CIR.0000058700.41738.12. View

17.

von Zur Muhlen C, Schiffer E, Zuerbig P, Kellmann M, Brasse M, Meert N . Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients. J Proteome Res. 2008; 8(1):335-45. DOI: 10.1021/pr800615t. View

18.

Birn H, Christensen E . Renal albumin absorption in physiology and pathology. Kidney Int. 2006; 69(3):440-9. DOI: 10.1038/sj.ki.5000141. View

19.

Gauer S, Yao J, Schoecklmann H, Sterzel R . Adhesion molecules in the glomerular mesangium. Kidney Int. 1997; 51(5):1447-53. DOI: 10.1038/ki.1997.198. View

20.

Rogers M, Clarke P, Noble J, Munro N, Paul A, Selby P . Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility. Cancer Res. 2003; 63(20):6971-83. View